Mandler; Markus

Patent Applications and Registrations

Patent applications and USPTO patent grants for Mandler; Markus.The latest application filed is for "treatment of alzheimer's disease (ad) with an aluminum salt".

Company Profile

7.14.24

Mandler; Markus - Vienna AT
Mandler; Markus - Fort Lauderdale FL

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Treatment Of Alzheimer's Disease (ad) With An Aluminum Salt App 20220062412 - Mandler; Markus ; et al.	2022-03-03
Treatment And Prevention Of Alzheimer's Disease (ad) App 20220000908 - Mandler; Markus ; et al.	2022-01-06
Treatment of Alzheimer's Disease (AD) with an aluminum salt Grant 11,147,873 - Mandler , et al. October 19, 2	2021-10-19
Treatment and prevention of alzheimer's disease (AD) Grant 11,065,273 - Mandler , et al. July 20, 2	2021-07-20
Treatment of Local Skin Hypotrophy Conditions App 20200369738 - MANDLER; Markus ; et al.	2020-11-26
Treatment And Prevention Of Alzheimer's Disease (ad) App 20200338192 - MANDLER; Markus ; et al.	2020-10-29
Mimotopes Of Alpha-synuclein And Vaccines Thereof For The Treatment Of Neurodegenerative Disorders App 20200254076 - Kind Code	2020-08-13
Treatment of alzheimer'S disease (AD) with an aluminum salt Grant 10,646,565 - Mandler , et al.	2020-05-12
Prevention And Treatment Of Non-melanoma Skin Cancer (nmsc) App 20200038487 - MANDLER; Markus ; et al.	2020-02-06
Mimotopes of alpha-synuclein and vaccines thereof for the treatment of neurodegenerative disorders Grant 10,517,935 - Mandler , et al. Dec	2019-12-31
Treatment of Alzheimer's disease (AD) with aluminum oxyhydroxide Grant 10,478,454 - Mandler , et al. Nov	2019-11-19
Method for detecting aSyn-specific antibodies in a biological sample Grant 9,964,547 - Staffler , et al. May 8, 2	2018-05-08
Mimotopes of alpha-synuclein and vaccines thereof for the treatment of neurodegenerative disorders Grant 9,724,399 - Mandler , et al. August 8, 2	2017-08-08
Mimotopes Of Alpha-synuclein And Vaccines Thereof For The Treatment Of Neurodegenerative Disorders App 20170158744 - MANDLER; Markus ; et al.	2017-06-08
Treatment And Prevention Of Alzheimer's Disease (ad) App 20170056495 - MANDLER; Markus ; et al.	2017-03-02
Treatment And Prevention Of Alzheimer's Disease (ad) App 20170049812 - MANDLER; Markus ; et al.	2017-02-23
Treatment And Prevention Of Alzheimer's Disease (ad) App 20170049810 - MANDLER; Markus ; et al.	2017-02-23
Method For Detecting Asyn-specific Antibodies In A Biological Sample App 20160054333 - STAFFLER; Guenther ; et al.	2016-02-25
METHOD FOR TREATING A beta-AMYLOIDOSIS App 20160008443 - MANDLER; Markus ; et al.	2016-01-14
Method For Treating A Synucleiopathy App 20150306194 - MANDLER; Markus ; et al.	2015-10-29
Composition App 20150093432 - Mandler; Markus ; et al.	2015-04-02
Compositions App 20150093431 - Mandler; Markus ; et al.	2015-04-02
Means for treating synucleinopathies Grant 8,828,942 - Mandler , et al. September 9, 2	2014-09-09
Compounds for treating beta-amyloidoses Grant 8,613,931 - Mandler , et al. December 24, 2	2013-12-24
Compounds For Treating Symptoms Associated With Parkinson's Disease App 20130287807 - MANDLER; Markus ; et al.	2013-10-31
Compounds For Treating Beta-amyloidoses App 20130230545 - MANDLER; Markus ; et al.	2013-09-05
Compounds for treating amyloidoses Grant 8,409,581 - Mandler , et al. April 2, 2	2013-04-02
Means For Treating Synucleinopathies App 20120156234 - Mandler; Markus ; et al.	2012-06-21
Compounds For Treating Amyloidoses App 20110171243 - Mandler; Markus ; et al.	2011-07-14
Compounds For Treating Beta-amyloidoses App 20110097351 - Mandler; Markus ; et al.	2011-04-28
Compounds For Treating Symptoms Associated With Parkinson's Disease App 20110092436 - Mandler; Markus ; et al.	2011-04-21
Mimotopes Of Alpha-synuclein And Vaccines Thereof For The Treatment Of Neurodegenerative Disorders App 20110092434 - Mandler; Markus ; et al.	2011-04-21

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.